Materialise NV Announces New Collaboration with DePuy Synthes
Leuven, Belgium – July 19, 2016. Materialise (Nasdaq: MTLS), announces a new collaboration with DePuy Synthes that will see Materialise’s patient-specific, craniomaxillofacial (CMF) implants being offered through DePuy Synthes TRUMATCH CMF Solutions in Australia and Europe, excluding France. Already included in TRUMATCH CMF is ProPlan CMF, a Materialise and DePuy Synthes solution for planning and patient-specific guides for CMF surgery.
Materialise Founder and CEO, Wilfried Vancraen, stated, “At Materialise, we strive to make medical 3D printing accessible to every researcher, engineer, and clinician, through an open platform of software and services that help customize patient treatment. Together with DePuy Synthes, we have successfully enabled better surgical outcomes through surgical planning and patient-specific guides, and are proud that this new collaboration will now empower even more CMF surgeons to discover the benefits of 3D-printed, patient-specific implants as well.”
Materialise has 25 years of experience in 3D planning and printing for medical applications, which includes the development of dedicated 3D visualization and planning software, engineering and design services and the production of 3D printed patient-specific guides and implants. In the field of CMF surgery, Materialise offers customized solutions that are in harmony with the morphology and physiology of each individual patient.
Patient-specific implants are not commercially available in the US and Canada